Chris H. Takimoto - 13 May 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Chief Medical Officer
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
13 May 2022
Net transactions value
+$10,214
Form type
4
Filing time
17 May 2022, 19:00:55 UTC
Previous filing
17 Mar 2022
Next filing
26 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $10,214 +825 +2.2% $12.38 37,802 13 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).